Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer ; volume:18 ; number:1 ; day:29 ; month:10 ; year:2018 ; pages:1-8 ; date:12.2018
BMC cancer ; 18, Heft 1 (29.10.2018), 1-8, 12.2018
- Creator
-
Gass, Paul
Lux, Michael P.
Rauh, Claudia
Hein, Alexander
Bani, Mayada R.
Fiessler, Cornelia
Hartmann, Arndt
Häberle, Lothar
Pretscher, Jutta
Erber, Ramona
Wachter, David L.
Schulz-Wendtland, Rüdiger
Beckmann, Matthias W.
Fasching, Peter Andreas
Wunderle, Marius
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4925-1
- URN
-
urn:nbn:de:101:1-2018121722470466311855
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gass, Paul
- Lux, Michael P.
- Rauh, Claudia
- Hein, Alexander
- Bani, Mayada R.
- Fiessler, Cornelia
- Hartmann, Arndt
- Häberle, Lothar
- Pretscher, Jutta
- Erber, Ramona
- Wachter, David L.
- Schulz-Wendtland, Rüdiger
- Beckmann, Matthias W.
- Fasching, Peter Andreas
- Wunderle, Marius
- SpringerLink (Online service)
Other Objects (12)
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
Breast Cancer and Genetic BRCA1/2 Testing in Routine Clinical Practice: Why, When and For Whom?
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
Breast Cancer and Genetic BRCA1/2 Testing in Routine Clinical Practice: Why, When and For Whom?
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
Breast Cancer and Genetic BRCA1/2 Testing in Routine Clinical Practice: Why, When and For Whom?
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center